As the new year begins, healthcare providers across Malaysia and the region are already observing a sharp rise in respiratory infections, an all-too-familiar pattern during the cooler, post-holiday months. Seasonal surges in influenza, RSV, COVID-19, and other respiratory pathogens are putting renewed pressure on hospitals and clinics to quickly identify and isolate infected individuals. In this critical period, Mediven stands ready with a range of real-time PCR respiratory panels designed to provide fast, accurate, and comprehensive pathogen detection.
Mediven’s respiratory panels are designed with outbreak season in mind when symptoms overlap and clinical decisions must be made quickly. The multiplex real-time PCR technology enables simultaneous detection of multiple respiratory pathogens in a single test run, significantly improving diagnostic efficiency.
GenoAmp® Multiplex Respiratory Panel
Covers a broad spectrum of common viral and bacterial respiratory pathogens, including:
- Influenza A & B
- RSV A & B
- Human Metapneumovirus
- Parainfluenza viruses
- Adenovirus
- SARS-CoV-2
- Mycoplasma pneumoniae
All Mediven respiratory PCR panels are:
- CE-IVD certified and MDA-registered
- Ready-to-use, reducing lab prep time
- Compatible with various real-time PCR machines and extraction platforms
- High-throughput friendly, ideal for busy clinical labs
- Clinically validated for high sensitivity and specificity
When respiratory infections surge, rapid and accurate diagnosis becomes essential, not only for delivering timely treatment, but also for preventing the spread of illness within communities. Mediven’s PCR panels equip clinicians with the tools to quickly identify the specific pathogen causing the infection, allowing for more targeted care. This precision helps avoid unnecessary use of antibiotics, ensures that contagious patients are isolated early, and ultimately leads to better patient outcomes through timely, informed clinical decisions.
As Malaysia and its neighbors brace for yet another wave of respiratory illness, Mediven’s locally developed PCR solutions are an essential part of the healthcare system’s response toolkite mpowering faster decisions and stronger disease control.
